Driehaus Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Driehaus Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23,638	Closed	-$5.13M	–	658
2017 Q1	$5.13M	Buy	+23,638	New	+$3.38M	0.18%	133
2015 Q4	–	Sell	-8,056	Closed	-$2.6M	–	654
2015 Q3	$2.6M	Sell	8,056 -690	-8%	-$303K	0.09%	232
2015 Q2	$3.48M	Buy	+8,746	New	+$3.72M	0.12%	216
2014 Q4	–	Sell	-7,256	Closed	-$1.4M	–	606
2014 Q3	$1.4M	Sell	7,256 -1,472	-17%	-$324K	0.05%	392
2014 Q2	$2.09M	Buy	8,728 +336	+4%	+$68.3K	0.07%	338
2014 Q1	$2.15M	Buy	8,392 +793	+10%	+$242K	0.07%	321
2013 Q4	$1.5M	Buy	+7,599	New	+$1.35M	0.05%	354

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Driehaus Capital Management's LUMO Position: Q2 2017 in Review

Driehaus Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017, closing a stake of 23,638 shares — an estimated $5.13M sold.

Driehaus Capital Management first reported a position in LUMO in Q4 2013 and held it in 7 quarters. The position peaked at $5.13M in Q1 2017. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

Driehaus Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Driehaus Capital Management sold 23,638 Lumos Pharma, Inc. Common Stock shares in Q2 2017, an estimated $5.13M.
Driehaus Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 7 quarters.
Driehaus Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $5.13M in Q1 2017.
110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on Driehaus Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.